IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Developing synthetic human hearts by utilizing 3D bioprinting technology.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/03/2022 |
Offer Price | |
Price Range $5.20 - $7.20 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $5.20 - $7.20 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Aegis Capital Corp. |
Company Data | |
---|---|
Headquarters | Buffalo Grove, IL, United States |
Founded | 2016 |
Employees | 12 |
Website biolife4d.com |